M. Octave-Prignot

895 total citations
28 papers, 729 citations indexed

About

M. Octave-Prignot is a scholar working on Radiation, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, M. Octave-Prignot has authored 28 papers receiving a total of 729 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Radiation, 12 papers in Pulmonary and Respiratory Medicine and 11 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in M. Octave-Prignot's work include Radiation Therapy and Dosimetry (11 papers), Nuclear Physics and Applications (10 papers) and Radiation Effects and Dosimetry (5 papers). M. Octave-Prignot is often cited by papers focused on Radiation Therapy and Dosimetry (11 papers), Nuclear Physics and Applications (10 papers) and Radiation Effects and Dosimetry (5 papers). M. Octave-Prignot collaborates with scholars based in Belgium, United States and South Africa. M. Octave-Prignot's co-authors include Pierre Scalliet, L. Gilbeau, André Wambersie, John Gueulette, Laurette Renard, Jean-François Rosier, S. Vynckier, V. Grégoire, Vincent Grégoire and B. Coster and has published in prestigious journals such as Radiology, British Journal of Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

M. Octave-Prignot

28 papers receiving 706 citations

Peers

M. Octave-Prignot
Tim Dijkema Netherlands
Arash Navran Netherlands
Laura Freedman United States
Lilie L. Lin United States
Joaquin G. Mira United States
Jennifer Bell Zoole United States
Tim Dijkema Netherlands
M. Octave-Prignot
Citations per year, relative to M. Octave-Prignot M. Octave-Prignot (= 1×) peers Tim Dijkema

Countries citing papers authored by M. Octave-Prignot

Since Specialization
Citations

This map shows the geographic impact of M. Octave-Prignot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Octave-Prignot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Octave-Prignot more than expected).

Fields of papers citing papers by M. Octave-Prignot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Octave-Prignot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Octave-Prignot. The network helps show where M. Octave-Prignot may publish in the future.

Co-authorship network of co-authors of M. Octave-Prignot

This figure shows the co-authorship network connecting the top 25 collaborators of M. Octave-Prignot. A scholar is included among the top collaborators of M. Octave-Prignot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Octave-Prignot. M. Octave-Prignot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Coche, Emmanuel, S. Vynckier, & M. Octave-Prignot. (2006). Pulmonary Embolism: Radiation Dose with Multi–Detector Row CT and Digital Angiography for Diagnosis. Radiology. 240(3). 690–697. 29 indexed citations
2.
Machiels, J-P., Lionel Duck, Brigitte Honhon, et al.. (2005). Phase II study of preoperative oxaliplatin, capecitabine and external beam radiotherapy in patients with rectal cancer: the RadiOxCape study. Annals of Oncology. 16(12). 1898–1905. 106 indexed citations
3.
Rosier, Jean-François, et al.. (2004). Role of 2′-2′ difluorodeoxycytidine (gemcitabine)-induced cell cycle dysregulation in radio-enhancement of human head and neck squamous cell carcinomas. Radiotherapy and Oncology. 70(1). 55–61. 9 indexed citations
4.
Zoetelief, J., et al.. (2001). Protocol for X-ray dosimetry in radiobiology. International Journal of Radiation Biology. 77(7). 817–835. 20 indexed citations
5.
Gilbeau, L., et al.. (2001). Comparison of setup accuracy of three different thermoplastic masks for the treatment of brain and head and neck tumors. Radiotherapy and Oncology. 58(2). 155–162. 173 indexed citations
6.
Gueulette, John, Jacobus Slabbert, L. Böhm, et al.. (2001). Proton RBE for early intestinal tolerance in mice after fractionated irradiation. Radiotherapy and Oncology. 61(2). 177–184. 39 indexed citations
7.
Gueulette, John, L. Böhm, Jacobus Slabbert, et al.. (2000). Proton relative biological effectiveness (RBE) for survival in mice after thoracic irradiation with fractionated doses. International Journal of Radiation Oncology*Biology*Physics. 47(4). 1051–1058. 37 indexed citations
8.
Grégoire, V., M. Beauduin, B. Coster, et al.. (1999). Effect of Gemcitabine on the Tolerance of the Lung to Single-Dose Irradiation in C3H Mice. Radiation Research. 151(6). 747–747. 9 indexed citations
9.
Rosier, Jean-François, et al.. (1998). Comparison of external radiotherapy, laser microsurgery and partial laryngectomy for the treatment of T1N0M0 glottic carcinomas: a retrospective evaluation. Radiotherapy and Oncology. 48(2). 175–183. 89 indexed citations
11.
Gueulette, John, L. Böhm, S. Vynckier, et al.. (1997). RBE variation as a function of depth in the 200-MeV proton beam produced at the National Accelerator Centre in Faure (South Africa). Radiotherapy and Oncology. 42(3). 303–309. 41 indexed citations
12.
Kirkove, Carine, et al.. (1993). Neutron Therapy of BladderCarcinoma: Can a High Rate ofSevere Complications BeAvoided in Neutron Therapy?. European Urology. 24(1). 52–57. 3 indexed citations
13.
Grégoire, V., et al.. (1989). Early repair kinetics of intestine and lung in mice, after fast neutron and photon irradiation.. PubMed. 165(4). 272–5. 3 indexed citations
14.
Gueulette, John, M. Octave-Prignot, & André Wambersie. (1984). Rbe of D(50)+be Neutrons, As a Function of the Dose Per Fraction, for Early Intestinal Tolerance in Mice. DIAL (Catholic University of Leuven). 5(3). 180–182. 4 indexed citations
15.
Octave-Prignot, M., et al.. (1983). Influence of dose rate on fast neutron OER and biological effectiveness determined for growth inhibition in Vicia faba.. Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)). 159(9). 576–83. 1 indexed citations
16.
Vynckier, S., et al.. (1982). Comparison of Neutron Therapy Beams Produced by 50 MEV Deuterons and 65 MEV Protons on Beryllium. Acta Radiologica Oncology. 21(4). 281–287. 7 indexed citations
17.
Richard, F., et al.. (1981). Present status of the treatment planning for d(50)-Be neutron beams and mixed schedules at "Cyclone".. PubMed. 77. 178–84. 1 indexed citations
18.
Bewley, D. K., J.P. Meulders, M. Octave-Prignot, & B C Page. (1980). Neutron beams from protons on beryllium. Physics in Medicine and Biology. 25(5). 887–892. 5 indexed citations
19.
Octave-Prignot, M., et al.. (1980). [Dosimetry and dose specification in neutrontherapy at "CYCLONE" (author's transl)].. PubMed. 63(6). 679–87. 1 indexed citations
20.
Wambersie, André, et al.. (1979). Effect of dose rate on intestinal tolerance in mice. Implications in radiotherapy. British Journal of Radiology. 52(614). 153–155. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026